Carregant...
The Pharmacological TAILS of Matrix Metalloproteinases and Their Inhibitors
Matrix metalloproteinases (MMPs) have been demonstrated to have both detrimental and protective functions in inflammatory diseases. Several MMP inhibitors, with the exception of Periostat(®), have failed in Phase III clinical trials. As an alternative strategy, recent efforts have been focussed on t...
Guardat en:
| Publicat a: | Pharmaceuticals (Basel) |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7823758/ https://ncbi.nlm.nih.gov/pubmed/33396445 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph14010031 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|